| Literature DB >> 33660184 |
Gabriel-Petrică Bălă1, Ruxandra-Mioara Râjnoveanu2, Emanuela Tudorache1, Radu Motișan3, Cristian Oancea1.
Abstract
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are constantly being reported in the literature. The goal of our review was to summarize the most important air pollutants and their impact on the main respiratory diseases (chronic obstructive pulmonary disease, asthma, lung cancer, idiopathic pulmonary fibrosis, respiratory infections, bronchiectasis, tuberculosis) to reduce both short- and the long-term exposure consequences. We considered the most important air pollutants, including sulfur dioxide, nitrogen dioxide, carbon monoxide, volatile organic compounds, ozone, particulate matter and biomass smoke, and observed their impact on pulmonary pathologies. We focused on respiratory pathologies, because air pollution potentiates the increase in respiratory diseases, and the evidence that air pollutants have a detrimental effect is growing. It is imperative to constantly improve policy initiatives on air quality in both high- and low-income countries.Entities:
Keywords: Air pollution; Asthma; Chronic obstructive pulmonary disease; Exposure; Lung cancer; Particulate matter; Respiratory diseases
Mesh:
Substances:
Year: 2021 PMID: 33660184 PMCID: PMC8099844 DOI: 10.1007/s11356-021-13208-x
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 4.223
Associations between air pollutants and respiratory diseases
| Authors | Disease | Air pollutant association | Ethnicity/nationality |
|---|---|---|---|
| Liang et al. ( | COPD | PM2.5 | China |
| Huang et al. ( | COPD | PM2.5 | Taiwan |
| Havet et al. ( | Asthma | PM10, O3 | France |
| Cadelis et al. ( | Asthma | PM10, PM2.5–10 | Caribbean |
| Akpinar-Elci et al. ( | Asthma | PM10, PM2.5–10 | Caribbean |
| Guarnieri and Balmes ( | Asthma | PM2.5, PM 10 | Meta-analyses |
| Xing et al. ( | Lung cancer | PM2.5, PM10, O3 | China |
| Hamra et al. ( | Lung cancer | PM2.5 | Meta-analyses |
| Gharibvand et al. ( | Lung cancer | PM2.5 | USA, Canada |
| Wang et al. ( | Lung cancer | PM2.5 | China |
| Winterbottom et al. ( | IPF | PM10 | USA |
| Johannson et al. ( | IPF | NO2, PM2.5, PM10 | USA |
| Johannson et al. ( | IPF | O3, NO2 | South Korea |
| Nsoh et al. ( | Respiratory infections | PM2.5 | Cameroon |
| Z. Zhang et al. ( | Respiratory infections | PM2.5, PM2.5–PM10 | China |
| Zheng et al. ( | Respiratory infections | PM10, NO2, SO2 | China |
| Goeminne et al. ( | Bronchiectasis | PM10, NO2 | UK |
| Garcia-Olivé et al. ( | Bronchiectasis | SO2 | Spain |
| Popovic et al. ( | Tuberculosis | PM2.5 | Asia, Europe, North America |
| Zhu et al. ( | Tuberculosis | PM10, NO2, SO2 | China |
| Lai et al. ( | Tuberculosis | PM2.5 | Taiwan |
| Jassal et al. ( | Tuberculosis | PM2.5 | USA |
| Li et al. ( | Tuberculosis | PM2.5 | China |
| Yao et al. ( | Tuberculosis | PM2.5, PM10, O3, CO | China |
Fig. 1NO2− nitrogen dioxide, SO2 sulfur dioxide, VOCs volatile organic compounds, CO carbon monoxide, PM2.5 particulate matter with diameter < 2.5 μm in diameter, PM10 particulate matter with diameter < 10 μm in diameter